A detailed history of Private Advisor Group, LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 25,600 shares of OVID stock, worth $33,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,600
Holding current value
$33,536
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$0.32 - $1.73 $8,192 - $44,288
25,600 New
25,600 $32,000
Q3 2020

Nov 02, 2020

SELL
$5.39 - $8.24 $10,133 - $15,491
-1,880 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$2.67 - $7.91 $5,019 - $14,870
1,880 New
1,880 $14,000

Others Institutions Holding OVID

About Ovid Therapeutics Inc.


  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $92.2M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.